37 Facts About Pat Cash

Patrick Hart Cash was born on 27 May 1965 and is an Australian former professional tennis player.

Pat Cash reached a career-high ATP singles ranking of world No 4 in May 1988 and a career-high ATP doubles ranking of world No 6 in August 1988.

Pat Cash came to the tennis world's attention as a prominent and promising junior player in the early 1980s.

Pat Cash was awarded a scholarship at the Australian Institute of Sport.

Pat Cash was ranked the No 1 junior player in the world in 1981.

In June 1982, Pat Cash won the junior doubles title at the French Open partnering John Frawley.

Pat Cash turned professional in late 1982 and won his first top-level singles title that year in Melbourne.

In 1983, Pat Cash became the youngest player to play in a Davis Cup final.

In 1984, Pat Cash reached the singles semifinals at both Wimbledon and the US Open.

Pat Cash lost in three sets in the Wimbledon semifinals to John McEnroe and was defeated in the semifinals at the US Open by Ivan Lendl, who won their match in a fifth-set tiebreaker.

Pat Cash finished the year in top 10 for the first time.

Pat Cash was the runner-up in the doubles competition at Wimbledon in both 1984 with Paul McNamee and 1985 with John Fitzgerald.

Pat Cash again won the decisive singles rubber, recovering from two sets down against Mikael Pernfors.

Just prior to Wimbledon in 1986, Pat Cash had an emergency appendix operation.

Pat Cash reached the quarterfinals of the competition, and during the championship he started the now common tradition of throwing wristbands and headbands into the crowd.

Pat Cash reached five singles finals, of which two were Grand Slam finals.

Pat Cash reached his first Grand Slam singles final at the Australian Open, where he lost in five sets to Stefan Edberg.

The crowning moment of Pat Cash's career came in 1987 at Wimbledon.

Pat Cash sealed the victory by climbing into the stands and up to the player's box at Centre Court, where he celebrated with his family, girlfriend, and coach, Ian Barclay.

Pat Cash thus started a Wimbledon tradition that has been followed by many other champions at Wimbledon and other Grand Slam tournaments since.

Pat Cash only dropped one set during the entire tournament.

In 1988, Pat Cash reached the Australian Open final for the second consecutive year and faced another Swede, Mats Wilander.

Pat Cash continued to play on the circuit on-and-off through the mid-1990s.

Pat Cash won his last top-level singles title in April 1990 at the Hong Kong Open.

Pat Cash established a reputation on the tour as a hard-fighting serve-and-volleyer and for wearing his trademark black-and-white checked headband and his cross earring.

For most of his career, Pat Cash was coached by Melbourne-born tennis coach Ian Barclay.

Pat Cash is the host of CNN's tennis-focused magazine show Open Court, and has worked as a TV co-commentator, primarily for the BBC.

Pat Cash continues to be a draw card on both the ATP and Champions Cup legends tours.

Pat Cash won the Hall of Fame event in Newport Rhode Island in 2008 and 2009.

Pat Cash has coached top players including Greg Rusedski and Mark Philippoussis.

Pat Cash opened a tennis academy on the Gold Coast of Australia and is opening academies in Ko Samui, Thailand and in the Caribbean St Vincent, St Lucia and Dominican Republic.

Pat Cash was inducted into the Sport Australia Hall of Fame in 2005.

Pat Cash won the over-45s Wimbledon doubles title with fellow Australian Mark Woodforde in 2010,2011,2012 and 2013.

In 2022, Pat Cash appeared on the third British series of The Masked Singer masked as "Bagpipes".

From 1990 through 2002 Pat Cash was married to Brazilian Emily Bendit.

In 2010, Pat Cash became a grandfather at age 44 when his daughter gave birth to a daughter.

Pat Cash was criticised for stating in an August 2021 interview with The Conservative Woman, broadcast online, that he had been taking Ivermectin for more than 15 months, claiming that "I'm living proof that I have been in the worst areas everywhere around the world and I haven't come close to getting COVID", despite the lack of evidence for the safety or efficacy of the drug for such measures.